These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16133064)

  • 21. Dose size and dosing interval determination.
    Ritschel WA
    Arzneimittelforschung; 1975 Sep; 25(9):1442-7. PubMed ID: 1242670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug dosage in renal insufficiency].
    Pogglitsch H; Waller J; Knauer T
    Wien Med Wochenschr; 1976 Nov; 126(47):661-5. PubMed ID: 997582
    [No Abstract]   [Full Text] [Related]  

  • 23. [Unclear on dose adjustment in renal impairment].
    Asker-Hagelberg C; Rydberg D; Hentschke M; Holm L; Rosenborg S; Elinder CG
    Lakartidningen; 2013 May 22-28; 110(21):1030-2. PubMed ID: 23805768
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug dosing in patients with renal insufficiency in a hospital setting using electronic prescribing and automated reporting of estimated glomerular filtration rate.
    Nielsen AL; Henriksen DP; Marinakis C; Hellebek A; Birn H; Nybo M; Søndergaard J; Nymark A; Pedersen C
    Basic Clin Pharmacol Toxicol; 2014 May; 114(5):407-13. PubMed ID: 24373255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interplay between drugs and the kidney in premature neonates.
    Schreuder MF; Bueters RR; Allegaert K
    Pediatr Nephrol; 2014 Nov; 29(11):2083-91. PubMed ID: 24217783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function.
    Spruill WJ; Wade WE; Cobb HH
    Clin Pharmacol Ther; 2009 Nov; 86(5):468-70. PubMed ID: 19844221
    [No Abstract]   [Full Text] [Related]  

  • 27. UK Renal Registry 16th annual report: chapter 13 clinical, haematological and biochemical parameters in patients receiving renal replacement therapy in paediatric centres in the uk in 2012: national and centre-specific analyses.
    Pruthi R; Maxwell H; Casula A; Braddon F; Lewis M; O'Brien C; Stojanovic J; Tse Y; Inward C; Sinha MD
    Nephron Clin Pract; 2013; 125(1-4):259-73. PubMed ID: 24662177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches.
    Dowling TC; Matzke GR; Murphy JE; Burckart GJ
    Pharmacotherapy; 2010 Aug; 30(8):776-86. PubMed ID: 20653353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug dosage should be based on renal function].
    Elinder CG; Bárány P; Heimbürger O
    Lakartidningen; 2013 Nov 20-26; 110(47):2119-20. PubMed ID: 24437103
    [No Abstract]   [Full Text] [Related]  

  • 30. A review of drug prescribing in children with end-stage renal failure.
    Trompeter RS
    Pediatr Nephrol; 1987 Apr; 1(2):183-94. PubMed ID: 3153278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug prescribing in renal failure.
    Bennett WM
    Drugs; 1979 Feb; 17(2):111-23. PubMed ID: 378644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of renal function.
    Barratt TM; Chantler C; Lederman S; Rigden SP
    Am J Kidney Dis; 1986 Apr; 7(4):347-9. PubMed ID: 3515915
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of the MDRD study equation to estimate kidney function for drug dosing.
    Stevens LA; Levey AS
    Clin Pharmacol Ther; 2009 Nov; 86(5):465-7. PubMed ID: 19844220
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug dosing in older patients with chronic kidney disease.
    Perrin E
    Am Fam Physician; 2007 Dec; 76(12):1766. PubMed ID: 18217516
    [No Abstract]   [Full Text] [Related]  

  • 35. Recent drug management advances in renal insufficiency.
    Fabre J; Balant L; Chavaz A
    Adv Nephrol Necker Hosp; 1974; 4():223-48. PubMed ID: 4219995
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
    Chan JC; Kodroff MB; Landwehr DM
    Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug prescribing in renal failure: dosing guidelines for adults.
    Bennett WM; Aronoff GR; Morrison G; Golper TA; Pulliam J; Wolfson M; Singer I
    Am J Kidney Dis; 1983 Nov; 3(3):155-93. PubMed ID: 6356890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of equations for dosing of medications requiring renal adjustment.
    Lessard BA; Zaiken K
    J Am Pharm Assoc (2003); 2013; 53(1):54-7. PubMed ID: 23636156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tripartite meeting. Paediatric regulatory guidelines: do they help in optimizing dose selection for children?
    Baber NS
    Br J Clin Pharmacol; 2005 Jun; 59(6):660-2. PubMed ID: 15948928
    [No Abstract]   [Full Text] [Related]  

  • 40. Guidelines and adenosine dosing in supraventricular tachycardia.
    Dixon J; Foster K; Wyllie J; Wren C
    Arch Dis Child; 2005 Nov; 90(11):1190-1. PubMed ID: 16243875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.